Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised double-blind placebo-controlled multiple-dose trial of Anti-IL-20 in rheumatoid arthritis
2010-021283-14Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing NNC109-0012 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Change in DAS28-CRP from baseline to week 12. Started Sep 2010; status: completed.
02
Drugs
fletikumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-021283-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021283-14.